Brian C. Vanderplas
Pfizer (United States)(US)
Publications by Year
Research Areas
Synthesis and Catalytic Reactions, Chemical Synthesis and Analysis, Chemical Synthesis and Reactions, Asymmetric Synthesis and Catalysis, Synthesis and Biological Evaluation
Most-Cited Works
- → Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin(2013)66 cited
- → Safe Execution of a Large-Scale Ozonolysis: Preparation of the Bisulfite Adduct of 2-Hydroxyindan-2-carboxaldehyde and Its Utility in a Reductive Amination(2003)54 cited
- → A Chemoenzymatic Route to Chiral Intermediates Used in the Multikilogram Synthesis of a Gamma Secretase Inhibitor(2017)39 cited
- → The preparation of β-substituted amines from mixtures of epoxide opening products via a common aziridinium ion intermediate(1999)28 cited
- → Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity(2008)24 cited
- → Development of a Practical and Efficient Synthesis of CP-945,598-01, a CB1 Antagonist for the Treatment of Obesity(2008)16 cited
- → Regioselective Addition of Mesitol to a 2,4-Dichloropyridine(2008)16 cited
- → Development of the Commercial Route for the Manufacture of a 5-Lipoxygenase Inhibitor PF-04191834(2015)14 cited
- → Synthesis of an optically active octahydro-2H-pyrido[1,2-a]pyrazine based CNS agent(1995)14 cited
- → Process Research and Scale-up of the κ-Opioid Receptor Agonist CJ-15,161 Drug Candidate(2006)13 cited